Column GROUP Iii-a, L.P. is 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 11 open-market trades across 4 companies since 2019, most recently 2026-02-23.
CIK 0001668085
8 open-market purchases totalling $9.6M since 2019, against 3 sales. Across 8 scored buys the stock is up 18.6% at ninety days, and 11.5 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RVMD | 2,151,026 | $383.0M |
| SRZN | 326,992 | $7.7M |
| NGM | 742,959 | $1.1M |
| TNYA | 1,958,509 | $728K |
| Total | $392.6M |
Shares reported on the most recent Form 4, priced at the 2026-02-24 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 75% | 63% | 75% |
| Avg Move | +5.8% | +11.4% | +18.6% |
| Alpha | +5.0% | +9.5% | +11.5% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TNYA | SELL | 2026-02-20 | 2026-02-24 | $0.61 | $503K | +43.2% | +13.6% | +26.4% |
| TNYA | SELL | 2026-02-10 | 2026-02-12 | $0.69 | $3.0M | -12.8% | +23.8% | +39.7% |
| SRZN | BUY | 2024-04-04 | 2024-04-17 | $15.50 | $3.0M | -1.4% | +1.4% | +0.8% |
| NGM | BUY | 2023-01-23 | 2023-01-25 | $5.00 | $50K | +0.4% | -14.4% | -23.3% |
| NGM | BUY | 2022-05-24 | 2022-05-26 | $13.41 | $820K | +1.1% | +7.8% | +19.5% |
| RVMD | SELL | 2020-11-16 | 2020-11-18 | $36.40 | $73.8M | +15.6% | +8.3% | +27.2% |
| NGM | BUY | 2020-08-27 | 2020-08-31 | $17.83 | $1.1M | -3.3% | -14.7% | +27.1% |
| NGM | BUY | 2020-07-24 | 2020-07-28 | $17.93 | $2.6M | +1.5% | -4.2% | -6.9% |
| NGM | BUY | 2020-04-08 | 2020-04-09 | $14.95 | $1.7M | +5.0% | +45.4% | +29.9% |
| NGM | BUY | 2019-11-11 | 2019-11-13 | $12.00 | $180 | +21.5% | +45.0% | +26.1% |
| NGM | BUY | 2019-10-09 | 2019-10-11 | $10.42 | $369K | +21.7% | +25.1% | +75.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.